Recent Publications

Should grade 3 endometrioid endometrial carcinoma be considered a type 2 cancer-a clinical and pathological evaluation. Voss MA, Ganesan R, Ludeman L, McCarthy K, Gornall R, Schaller G, Wei W, Sundar S. Gynecol Oncol. 2012 Jan;124(1):15-20

Tetraspanin CD151 is a novel prognostic marker in poor outcome endometrial cancer. Voss MA, Gordon N, Maloney S, Ganesan R, Ludeman L, McCarthy K, Gornall R, Schaller G, Wei W, Berditchevski F, Sundar S.Br J Cancer. 2011 May 10;104(10):1611-8

A case report of recurrent endometriosis following Tibolone hormone replacement therapy. Sundar SS, Gornall RJ, Kerr-Wilson R, Swingler GR, Kinder RB, McCarthy K.J Obstet Gynaecol. 2007 May;27(4):433-4

Advances in the management of cervical cancer. Sundar SS, Gornall RJ, Kehoe ST.J Br Menopause Soc. 2005 Sep;11(3):91-5

Recurrent high grade cervical intraepithelial neoplasia in a patient with cyclical neutropaenia: an analysis of HPV status. Gornall R, Lanhan S, Dhundee J, Woolas R.J Obstet Gynaecol. 2000 Jul;20(4):438

Influence of omental biopsy on adjuvant treatment field in clinical Stage I endometrial carcinoma. Nieto JJ, Gornall R, Toms E, Clarkson S, Hogston P, Woolas RP.BJOG. 2002 May;109(5):576-8

Resection of recurrent bulky gynaecological side wall malignancy with iliac vessel reconstruction. Gornall RJ, Standfield N, deSouza NM, Aachi VR, McIndoe GA.BJOG. 2001 Dec;108(12):

A case report of recurrent endometriosis following Tibolone hormone replacement therapy. Sundar SS, Gornall RJ, Kerr-Wilson R, Swingler GR, Kinder RB, McCarthy K. J Obstet Gynaecol. 2007 May;27(4):433-4. No abstract available.

Endometrial adenocarcinoma following ThermaChoice balloon endometrial ablation. Lee JK, Gupta J, McCarthy K, Gornall RJ .J Obstet Gynaecol. 2005 Nov;25(8):825-6.

Advances in the management of cervical cancer. Sundar SS, Gornall RJ, Kehoe ST.J Br Menopause Soc. 2005 Sep;11(3):91-5.

Recurrent high grade cervical intraepithelial neoplasia in a patient with cyclical neutropaenia: an analysis of HPV status. Gornall R, Lanhan S, Dhundee J, Woolas R.J Obstet Gynaecol. 2000 Jul;20(4):438.

Topical antiseptic agent after large loop excision of the transformation zone: results of a randomised controlled trial. Gornall RJ, Beynon DW, Shepherd NJ, Boyd IE.J Obstet Gynaecol. 1999 Sep;19(5):509-10.

Influence of omental biopsy on adjuvant treatment field in clinical Stage I endometrial carcinoma. Nieto JJ, Gornall R, Toms E, Clarkson S, Hogston P, Woolas RP.BJOG. 2002 May;109(5):576-8.

Resection of recurrent bulky gynaecological side wall malignancy with iliac vessel reconstruction. Gornall RJ, Standfield N, deSouza NM, Aachi VR, McIndoe GA.BJOG. 2001 Dec;108(12):1305-8. No abstract available.

Is conservative treatment for adenocarcinoma in situ of the cervix safe? Soutter WP, Haidopoulos D, Gornall RJ, McIndoe GA, Fox J, Mason WP, Flanagan A, Nicholas N, Barker F, Abrahams J, Lampert I, Sarhanis P. BJOG. 2001 Nov;108(11):1184-9.

Investigation of women with endometrial carcinoma using serum vascular endothelial growth factor (VEGF) measurement. Gornall RJ, Anthony FW, Coombes EJ, Hogston P, Woolas RP. Int J Gynecol Cancer. 2001 Mar-Apr;11(2):164-6.

Interval cervical cancer following treatment for cervical intraepithelial neoplasia. Gornall RJ, Boyd IE, Manolitsas T, Herbert A. Int J Gynecol Cancer. 2000 May;10(3):198-202.

Glandular abnormalities on cervical smear: a study to compare the accuracy of cytological diagnosis with underlying pathology. Gornall RJ, Singh N, Noble W, Boyd IE, Hitchcock A. Eur J Gynaecol Oncol. 2000;21(1):49-52.

Six year survey of screening for Down’s syndrome by maternal age and mid-trimester ultrasound scans. Howe DT, Gornall R, Wellesley D, Boyle T, Barber J. BMJ. 2000 Mar 4;320(7235):606-10.

Can flexible sigmoidoscopy predict need for colorectal surgery in ovarian carcinoma? Gornall Talbot R. Eur J Gynaecol Oncol. 1999;20(1):13-5.RJ,

p53 polymorphism and risk of cervical cancer. Lanham S, Campbell I, Watt P, Gornall R.Lancet. 1998 Nov 14;352(9140):1631

TP53 intron 6 polymorphism and the risk of ovarian and breast cancer. Mavridou D, Gornall R, Campbell IG, Eccles DM. Br J Cancer. 1998 Feb;77(4):676-7.

A randomised placebo controlled trial of loop diuretics in moderate/severe pre-eclampsia, following delivery. Matthews G, Gornall R, Saunders NJ. J Obstet Gynaecol. 1997 Jan;17(1):30-2.

CURRENT WORK UTILISING POPULATION DATA

Kaushik S, Hounsome L, Murdoch J, Poirier V, Gornall R, Verne J. Variations in the quality of end of life care for gynaecological cancers in the UK – evaluation of national data. NCRI, November, 2012.

Kaushik S, Hounsome L, Murdoch J, Poirier V, Gornall R, Verne J. End of Life Care in Gynaecological Cancer in the UK: Resource utilization. NCIN June 2012.

Kaushik S, Hounsome L, Murdoch J, Poirier V, Gornall R, Verne J. End of Life Care in Gynaecological Cancer in the UK: Impact Factors’. NCIN June 2012.

Kaushik S, Poirier V, Murdoch J, Hillaby K, Gornall R, Verne J. Ovarian cancer survival – are we improving? BGCS, 2011 and NCIN June 2012.